Industry Research Reports

Home > Reports > Service & Software > Global Decentralized Clinical Trial Platforms Market Research Report 2025

Global Decentralized Clinical Trial Platforms Market Research Report 2025

Industry: Service & Software

Published Date: 2025-03-11

Pages: 102 Pages

Report ld: 4637762

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Decentralized Clinical Trial Platforms was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.

North American market for Decentralized Clinical Trial Platforms is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Decentralized Clinical Trial Platforms is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Decentralized Clinical Trial Platforms in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Decentralized Clinical Trial Platforms include Medidata, IQVIA, Veeva Systems, Castor, Delve Health, Jeeva, Signant Health, Clinical Ink, ObvioHealth, THREAD, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trial Platforms, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trial Platforms.

The Decentralized Clinical Trial Platforms market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Decentralized Clinical Trial Platforms market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Decentralized Clinical Trial Platforms companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Medidata
IQVIA
Veeva Systems
Castor
Delve Health
Jeeva
Signant Health
Clinical Ink
ObvioHealth
THREAD
Science 37
Medable, Clario
Aparito
Viedoc Technologies
Crucial Data Solutions
Medrio
Alira Health
Fortrea
Huma
Cliniv Health Tech
Datacubed Health

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Cloud Based
Web Based

Segment by Application

Pharmaceutical Companies
Biotechnology Firms
Contract Research Organizations (CROs)
Healthcare Institutions

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Decentralized Clinical Trial Platforms company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Decentralized Clinical Trial Platforms Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cloud Based

1.2.3 Web Based

1.3 Market by Application

1.3.1 Global Decentralized Clinical Trial Platforms Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Companies

1.3.3 Biotechnology Firms

1.3.4 Contract Research Organizations (CROs)

1.3.5 Healthcare Institutions

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Decentralized Clinical Trial Platforms Market Perspective (2020-2031)

2.2 Global Decentralized Clinical Trial Platforms Growth Trends by Region

2.2.1 Global Decentralized Clinical Trial Platforms Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Decentralized Clinical Trial Platforms Historic Market Size by Region (2020-2025)

2.2.3 Decentralized Clinical Trial Platforms Forecasted Market Size by Region (2026-2031)

2.3 Decentralized Clinical Trial Platforms Market Dynamics

2.3.1 Decentralized Clinical Trial Platforms Industry Trends

2.3.2 Decentralized Clinical Trial Platforms Market Drivers

2.3.3 Decentralized Clinical Trial Platforms Market Challenges

2.3.4 Decentralized Clinical Trial Platforms Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Decentralized Clinical Trial Platforms Players by Revenue

3.1.1 Global Top Decentralized Clinical Trial Platforms Players by Revenue (2020-2025)

3.1.2 Global Decentralized Clinical Trial Platforms Revenue Market Share by Players (2020-2025)

3.2 Global Decentralized Clinical Trial Platforms Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Decentralized Clinical Trial Platforms Revenue

3.4 Global Decentralized Clinical Trial Platforms Market Concentration Ratio

3.4.1 Global Decentralized Clinical Trial Platforms Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Decentralized Clinical Trial Platforms Revenue in 2024

3.5 Global Key Players of Decentralized Clinical Trial Platforms Head office and Area Served

3.6 Global Key Players of Decentralized Clinical Trial Platforms, Product and Application

3.7 Global Key Players of Decentralized Clinical Trial Platforms, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Decentralized Clinical Trial Platforms Breakdown Data by Type

4.1 Global Decentralized Clinical Trial Platforms Historic Market Size by Type (2020-2025)

4.2 Global Decentralized Clinical Trial Platforms Forecasted Market Size by Type (2026-2031)

5 Decentralized Clinical Trial Platforms Breakdown Data by Application

5.1 Global Decentralized Clinical Trial Platforms Historic Market Size by Application (2020-2025)

5.2 Global Decentralized Clinical Trial Platforms Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Decentralized Clinical Trial Platforms Market Size (2020-2031)

6.2 North America Decentralized Clinical Trial Platforms Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Decentralized Clinical Trial Platforms Market Size by Country (2020-2025)

6.4 North America Decentralized Clinical Trial Platforms Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Decentralized Clinical Trial Platforms Market Size (2020-2031)

7.2 Europe Decentralized Clinical Trial Platforms Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Decentralized Clinical Trial Platforms Market Size by Country (2020-2025)

7.4 Europe Decentralized Clinical Trial Platforms Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Decentralized Clinical Trial Platforms Market Size (2020-2031)

8.2 Asia-Pacific Decentralized Clinical Trial Platforms Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Decentralized Clinical Trial Platforms Market Size by Region (2020-2025)

8.4 Asia-Pacific Decentralized Clinical Trial Platforms Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Decentralized Clinical Trial Platforms Market Size (2020-2031)

9.2 Latin America Decentralized Clinical Trial Platforms Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Decentralized Clinical Trial Platforms Market Size by Country (2020-2025)

9.4 Latin America Decentralized Clinical Trial Platforms Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Decentralized Clinical Trial Platforms Market Size (2020-2031)

10.2 Middle East & Africa Decentralized Clinical Trial Platforms Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2020-2025)

10.4 Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medidata

11.1.1 Medidata Company Details

11.1.2 Medidata Business Overview

11.1.3 Medidata Decentralized Clinical Trial Platforms Introduction

11.1.4 Medidata Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.1.5 Medidata Recent Development

11.2 IQVIA

11.2.1 IQVIA Company Details

11.2.2 IQVIA Business Overview

11.2.3 IQVIA Decentralized Clinical Trial Platforms Introduction

11.2.4 IQVIA Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.2.5 IQVIA Recent Development

11.3 Veeva Systems

11.3.1 Veeva Systems Company Details

11.3.2 Veeva Systems Business Overview

11.3.3 Veeva Systems Decentralized Clinical Trial Platforms Introduction

11.3.4 Veeva Systems Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.3.5 Veeva Systems Recent Development

11.4 Castor

11.4.1 Castor Company Details

11.4.2 Castor Business Overview

11.4.3 Castor Decentralized Clinical Trial Platforms Introduction

11.4.4 Castor Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.4.5 Castor Recent Development

11.5 Delve Health

11.5.1 Delve Health Company Details

11.5.2 Delve Health Business Overview

11.5.3 Delve Health Decentralized Clinical Trial Platforms Introduction

11.5.4 Delve Health Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.5.5 Delve Health Recent Development

11.6 Jeeva

11.6.1 Jeeva Company Details

11.6.2 Jeeva Business Overview

11.6.3 Jeeva Decentralized Clinical Trial Platforms Introduction

11.6.4 Jeeva Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.6.5 Jeeva Recent Development

11.7 Signant Health

11.7.1 Signant Health Company Details

11.7.2 Signant Health Business Overview

11.7.3 Signant Health Decentralized Clinical Trial Platforms Introduction

11.7.4 Signant Health Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.7.5 Signant Health Recent Development

11.8 Clinical Ink

11.8.1 Clinical Ink Company Details

11.8.2 Clinical Ink Business Overview

11.8.3 Clinical Ink Decentralized Clinical Trial Platforms Introduction

11.8.4 Clinical Ink Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.8.5 Clinical Ink Recent Development

11.9 ObvioHealth

11.9.1 ObvioHealth Company Details

11.9.2 ObvioHealth Business Overview

11.9.3 ObvioHealth Decentralized Clinical Trial Platforms Introduction

11.9.4 ObvioHealth Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.9.5 ObvioHealth Recent Development

11.10 THREAD

11.10.1 THREAD Company Details

11.10.2 THREAD Business Overview

11.10.3 THREAD Decentralized Clinical Trial Platforms Introduction

11.10.4 THREAD Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.10.5 THREAD Recent Development

11.11 Science 37

11.11.1 Science 37 Company Details

11.11.2 Science 37 Business Overview

11.11.3 Science 37 Decentralized Clinical Trial Platforms Introduction

11.11.4 Science 37 Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.11.5 Science 37 Recent Development

11.12 Medable, Clario

11.12.1 Medable, Clario Company Details

11.12.2 Medable, Clario Business Overview

11.12.3 Medable, Clario Decentralized Clinical Trial Platforms Introduction

11.12.4 Medable, Clario Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.12.5 Medable, Clario Recent Development

11.13 Aparito

11.13.1 Aparito Company Details

11.13.2 Aparito Business Overview

11.13.3 Aparito Decentralized Clinical Trial Platforms Introduction

11.13.4 Aparito Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.13.5 Aparito Recent Development

11.14 Viedoc Technologies

11.14.1 Viedoc Technologies Company Details

11.14.2 Viedoc Technologies Business Overview

11.14.3 Viedoc Technologies Decentralized Clinical Trial Platforms Introduction

11.14.4 Viedoc Technologies Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.14.5 Viedoc Technologies Recent Development

11.15 Crucial Data Solutions

11.15.1 Crucial Data Solutions Company Details

11.15.2 Crucial Data Solutions Business Overview

11.15.3 Crucial Data Solutions Decentralized Clinical Trial Platforms Introduction

11.15.4 Crucial Data Solutions Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.15.5 Crucial Data Solutions Recent Development

11.16 Medrio

11.16.1 Medrio Company Details

11.16.2 Medrio Business Overview

11.16.3 Medrio Decentralized Clinical Trial Platforms Introduction

11.16.4 Medrio Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.16.5 Medrio Recent Development

11.17 Alira Health

11.17.1 Alira Health Company Details

11.17.2 Alira Health Business Overview

11.17.3 Alira Health Decentralized Clinical Trial Platforms Introduction

11.17.4 Alira Health Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.17.5 Alira Health Recent Development

11.18 Fortrea

11.18.1 Fortrea Company Details

11.18.2 Fortrea Business Overview

11.18.3 Fortrea Decentralized Clinical Trial Platforms Introduction

11.18.4 Fortrea Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.18.5 Fortrea Recent Development

11.19 Huma

11.19.1 Huma Company Details

11.19.2 Huma Business Overview

11.19.3 Huma Decentralized Clinical Trial Platforms Introduction

11.19.4 Huma Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.19.5 Huma Recent Development

11.20 Cliniv Health Tech

11.20.1 Cliniv Health Tech Company Details

11.20.2 Cliniv Health Tech Business Overview

11.20.3 Cliniv Health Tech Decentralized Clinical Trial Platforms Introduction

11.20.4 Cliniv Health Tech Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.20.5 Cliniv Health Tech Recent Development

11.21 Datacubed Health

11.21.1 Datacubed Health Company Details

11.21.2 Datacubed Health Business Overview

11.21.3 Datacubed Health Decentralized Clinical Trial Platforms Introduction

11.21.4 Datacubed Health Revenue in Decentralized Clinical Trial Platforms Business (2020-2025)

11.21.5 Datacubed Health Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Decentralized Clinical Trial Platforms Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cloud Based

Table 3. Key Players of Web Based

Table 4. Global Decentralized Clinical Trial Platforms Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Decentralized Clinical Trial Platforms Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Decentralized Clinical Trial Platforms Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Decentralized Clinical Trial Platforms Market Share by Region (2020-2025)

Table 8. Global Decentralized Clinical Trial Platforms Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Decentralized Clinical Trial Platforms Market Share by Region (2026-2031)

Table 10. Decentralized Clinical Trial Platforms Market Trends

Table 11. Decentralized Clinical Trial Platforms Market Drivers

Table 12. Decentralized Clinical Trial Platforms Market Challenges

Table 13. Decentralized Clinical Trial Platforms Market Restraints

Table 14. Global Decentralized Clinical Trial Platforms Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Decentralized Clinical Trial Platforms Market Share by Players (2020-2025)

Table 16. Global Top Decentralized Clinical Trial Platforms Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trial Platforms as of 2024)

Table 17. Ranking of Global Top Decentralized Clinical Trial Platforms Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Decentralized Clinical Trial Platforms Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Decentralized Clinical Trial Platforms, Headquarters and Area Served

Table 20. Global Key Players of Decentralized Clinical Trial Platforms, Product and Application

Table 21. Global Key Players of Decentralized Clinical Trial Platforms, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Decentralized Clinical Trial Platforms Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Decentralized Clinical Trial Platforms Revenue Market Share by Type (2020-2025)

Table 25. Global Decentralized Clinical Trial Platforms Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Decentralized Clinical Trial Platforms Revenue Market Share by Type (2026-2031)

Table 27. Global Decentralized Clinical Trial Platforms Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Decentralized Clinical Trial Platforms Revenue Market Share by Application (2020-2025)

Table 29. Global Decentralized Clinical Trial Platforms Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Decentralized Clinical Trial Platforms Revenue Market Share by Application (2026-2031)

Table 31. North America Decentralized Clinical Trial Platforms Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Decentralized Clinical Trial Platforms Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Decentralized Clinical Trial Platforms Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Decentralized Clinical Trial Platforms Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Decentralized Clinical Trial Platforms Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Decentralized Clinical Trial Platforms Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Decentralized Clinical Trial Platforms Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Decentralized Clinical Trial Platforms Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Decentralized Clinical Trial Platforms Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Decentralized Clinical Trial Platforms Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Decentralized Clinical Trial Platforms Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Decentralized Clinical Trial Platforms Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Decentralized Clinical Trial Platforms Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2026-2031) & (US$ Million)

Table 46. Medidata Company Details

Table 47. Medidata Business Overview

Table 48. Medidata Decentralized Clinical Trial Platforms Product

Table 49. Medidata Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 50. Medidata Recent Development

Table 51. IQVIA Company Details

Table 52. IQVIA Business Overview

Table 53. IQVIA Decentralized Clinical Trial Platforms Product

Table 54. IQVIA Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 55. IQVIA Recent Development

Table 56. Veeva Systems Company Details

Table 57. Veeva Systems Business Overview

Table 58. Veeva Systems Decentralized Clinical Trial Platforms Product

Table 59. Veeva Systems Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 60. Veeva Systems Recent Development

Table 61. Castor Company Details

Table 62. Castor Business Overview

Table 63. Castor Decentralized Clinical Trial Platforms Product

Table 64. Castor Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 65. Castor Recent Development

Table 66. Delve Health Company Details

Table 67. Delve Health Business Overview

Table 68. Delve Health Decentralized Clinical Trial Platforms Product

Table 69. Delve Health Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 70. Delve Health Recent Development

Table 71. Jeeva Company Details

Table 72. Jeeva Business Overview

Table 73. Jeeva Decentralized Clinical Trial Platforms Product

Table 74. Jeeva Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 75. Jeeva Recent Development

Table 76. Signant Health Company Details

Table 77. Signant Health Business Overview

Table 78. Signant Health Decentralized Clinical Trial Platforms Product

Table 79. Signant Health Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 80. Signant Health Recent Development

Table 81. Clinical Ink Company Details

Table 82. Clinical Ink Business Overview

Table 83. Clinical Ink Decentralized Clinical Trial Platforms Product

Table 84. Clinical Ink Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 85. Clinical Ink Recent Development

Table 86. ObvioHealth Company Details

Table 87. ObvioHealth Business Overview

Table 88. ObvioHealth Decentralized Clinical Trial Platforms Product

Table 89. ObvioHealth Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 90. ObvioHealth Recent Development

Table 91. THREAD Company Details

Table 92. THREAD Business Overview

Table 93. THREAD Decentralized Clinical Trial Platforms Product

Table 94. THREAD Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 95. THREAD Recent Development

Table 96. Science 37 Company Details

Table 97. Science 37 Business Overview

Table 98. Science 37 Decentralized Clinical Trial Platforms Product

Table 99. Science 37 Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 100. Science 37 Recent Development

Table 101. Medable, Clario Company Details

Table 102. Medable, Clario Business Overview

Table 103. Medable, Clario Decentralized Clinical Trial Platforms Product

Table 104. Medable, Clario Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 105. Medable, Clario Recent Development

Table 106. Aparito Company Details

Table 107. Aparito Business Overview

Table 108. Aparito Decentralized Clinical Trial Platforms Product

Table 109. Aparito Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 110. Aparito Recent Development

Table 111. Viedoc Technologies Company Details

Table 112. Viedoc Technologies Business Overview

Table 113. Viedoc Technologies Decentralized Clinical Trial Platforms Product

Table 114. Viedoc Technologies Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 115. Viedoc Technologies Recent Development

Table 116. Crucial Data Solutions Company Details

Table 117. Crucial Data Solutions Business Overview

Table 118. Crucial Data Solutions Decentralized Clinical Trial Platforms Product

Table 119. Crucial Data Solutions Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 120. Crucial Data Solutions Recent Development

Table 121. Medrio Company Details

Table 122. Medrio Business Overview

Table 123. Medrio Decentralized Clinical Trial Platforms Product

Table 124. Medrio Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 125. Medrio Recent Development

Table 126. Alira Health Company Details

Table 127. Alira Health Business Overview

Table 128. Alira Health Decentralized Clinical Trial Platforms Product

Table 129. Alira Health Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 130. Alira Health Recent Development

Table 131. Fortrea Company Details

Table 132. Fortrea Business Overview

Table 133. Fortrea Decentralized Clinical Trial Platforms Product

Table 134. Fortrea Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 135. Fortrea Recent Development

Table 136. Huma Company Details

Table 137. Huma Business Overview

Table 138. Huma Decentralized Clinical Trial Platforms Product

Table 139. Huma Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 140. Huma Recent Development

Table 141. Cliniv Health Tech Company Details

Table 142. Cliniv Health Tech Business Overview

Table 143. Cliniv Health Tech Decentralized Clinical Trial Platforms Product

Table 144. Cliniv Health Tech Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 145. Cliniv Health Tech Recent Development

Table 146. Datacubed Health Company Details

Table 147. Datacubed Health Business Overview

Table 148. Datacubed Health Decentralized Clinical Trial Platforms Product

Table 149. Datacubed Health Revenue in Decentralized Clinical Trial Platforms Business (2020-2025) & (US$ Million)

Table 150. Datacubed Health Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

Table 154. Authors List of This Report

List of Figures

Figure 1. Decentralized Clinical Trial Platforms Picture

Figure 2. Global Decentralized Clinical Trial Platforms Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Decentralized Clinical Trial Platforms Market Share by Type: 2024 VS 2031

Figure 4. Cloud Based Features

Figure 5. Web Based Features

Figure 6. Global Decentralized Clinical Trial Platforms Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Decentralized Clinical Trial Platforms Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical Companies Case Studies

Figure 9. Biotechnology Firms Case Studies

Figure 10. Contract Research Organizations (CROs) Case Studies

Figure 11. Healthcare Institutions Case Studies

Figure 12. Decentralized Clinical Trial Platforms Report Years Considered

Figure 13. Global Decentralized Clinical Trial Platforms Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Decentralized Clinical Trial Platforms Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Decentralized Clinical Trial Platforms Market Share by Region: 2024 VS 2031

Figure 16. Global Decentralized Clinical Trial Platforms Market Share by Players in 2024

Figure 17. Global Top Decentralized Clinical Trial Platforms Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trial Platforms as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Decentralized Clinical Trial Platforms Revenue in 2024

Figure 19. North America Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Decentralized Clinical Trial Platforms Market Share by Country (2020-2031)

Figure 21. United States Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Decentralized Clinical Trial Platforms Market Share by Country (2020-2031)

Figure 25. Germany Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Decentralized Clinical Trial Platforms Market Share by Region (2020-2031)

Figure 33. China Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Decentralized Clinical Trial Platforms Market Share by Country (2020-2031)

Figure 41. Mexico Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Decentralized Clinical Trial Platforms Market Share by Country (2020-2031)

Figure 45. Turkey Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Decentralized Clinical Trial Platforms Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Medidata Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 49. IQVIA Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 50. Veeva Systems Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 51. Castor Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 52. Delve Health Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 53. Jeeva Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 54. Signant Health Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 55. Clinical Ink Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 56. ObvioHealth Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 57. THREAD Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 58. Science 37 Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 59. Medable, Clario Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 60. Aparito Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 61. Viedoc Technologies Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 62. Crucial Data Solutions Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 63. Medrio Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 64. Alira Health Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 65. Fortrea Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 66. Huma Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 67. Cliniv Health Tech Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 68. Datacubed Health Revenue Growth Rate in Decentralized Clinical Trial Platforms Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Decentralized Clinical Trial Platforms market? zhanKai

The top companies in the global Decentralized Clinical Trial Platforms market are Medidata、IQVIA、Veeva Systems.

Related Reports

Global Decentralized Clinical Trial Platforms Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Decentralized Clinical Trial Platforms market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 116
USD 4250.00
(Single User License)
Global Decentralized Clinical Trial Platforms Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Decentralized Clinical Trial Platforms market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 174
USD 4900.00
(Single User License)
Decentralized Clinical Trial Platforms - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Decentralized Clinical Trial Platforms was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 147
USD 3950.00
(Single User License)
Global Decentralized Clinical Trial Platforms Market Research Report 2026
The global Decentralized Clinical Trial Platforms market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 158
USD 2900.00
(Single User License)
Global Decentralized Clinical Trial Platforms Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Decentralized Clinical Trial Platforms market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 118
USD 4250.00
(Single User License)
Global Decentralized Clinical Trial Platforms Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Decentralized Clinical Trial Platforms market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 171
USD 4900.00
(Single User License)
Decentralized Clinical Trial Platforms - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Decentralized Clinical Trial Platforms was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 143
USD 3950.00
(Single User License)
Global Decentralized Clinical Trial Platforms Market Research Report 2024
Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.
Published Date: 2024-07-07
Pages: 109
USD 2900.00
(Single User License)
Global and United States Decentralized Clinical Trial Platforms Market Report & Forecast 2024-2030
Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.
Published Date: 2024-07-07
Pages: 149
USD 4350.00
(Single User License)
Global Decentralized Clinical Trial Platforms Market Insights, Forecast to 2030
Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.
Published Date: 2024-07-07
Pages: 166
USD 4900.00
(Single User License)

Global Decentralized Clinical Trial Platforms Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Decentralized Clinical Trial Platforms market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 116
USD 4250.00 (Single User License)
Global Decentralized Clinical Trial Platforms Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Decentralized Clinical Trial Platforms market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 174
USD 4900.00 (Single User License)
Decentralized Clinical Trial Platforms - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Decentralized Clinical Trial Platforms was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 147
USD 3950.00 (Single User License)
Global Decentralized Clinical Trial Platforms Market Research Report 2026
The global Decentralized Clinical Trial Platforms market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 158
USD 2900.00 (Single User License)
Global Decentralized Clinical Trial Platforms Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Decentralized Clinical Trial Platforms market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 118
USD 4250.00 (Single User License)
Global Decentralized Clinical Trial Platforms Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Decentralized Clinical Trial Platforms market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 171
USD 4900.00 (Single User License)
Decentralized Clinical Trial Platforms - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Decentralized Clinical Trial Platforms was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 143
USD 3950.00 (Single User License)
Global Decentralized Clinical Trial Platforms Market Research Report 2024
Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.
Published: 2024-07-07
Pages: 109
USD 2900.00 (Single User License)
Global and United States Decentralized Clinical Trial Platforms Market Report & Forecast 2024-2030
Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.
Published: 2024-07-07
Pages: 149
USD 4350.00 (Single User License)
Global Decentralized Clinical Trial Platforms Market Insights, Forecast to 2030
Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.
Published: 2024-07-07
Pages: 166
USD 4900.00 (Single User License)